PARIS -- More than 100 investigators are racing to piece together how thieves pulled off the brazen heist at the Louvre ...
In this video, Andres Deik, MD, MSEd, FAAN, discusses the results of the CYCLE-II trial, presented at the 2025 International Congress of Parkinson’s Disease and Movement Disorders.
Skin irritation or inflammation "triggers a resting hair follicle to go into a growth phase," Dr. George Cotsarelis told ...
The gene-editing biotech Intellia Therapeutics said it had paused two trials of one of its lead experimental treatments.
A class of diabetes and weight-loss drugs, known as GLP-1 receptor agonists, may do far more than trim waistlines. Early studies reveal they could also ease alcohol, nicotine, and drug dependence by ...
The Chosun Ilbo on MSN
Supreme Court's Naive Ruling Sparks Political Backlash
Anyway, the Chief Justice or Justices are too naive in some aspects.”A legal professional with a background as a prosecutor ...
The BJP-led Delhi government, in collaboration with IIT Kanpur, begins cloud-seeding trials to induce artificial rain and ...
America can still be a beacon like it was in the dark days of the Nuremberg trials, which showed the world what a moral force ...
Intellia paused both trials after receiving a report of grade 4 liver enzymes and increased total bilirubin in a patient in ...
For biopharma, reaching the right patients at the right time is essential for both clinical and commercial success. The right ...
Zenas Biopharma’s lead autoimmune drug has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study. | Zenas Biopharma’s lead autoimmune drug ...
Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results